Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor

NCT07681375 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-07-02

No results posted yet for this study

Summary

To evaluate the feasibility of the DexBasal Study System

Conditions

Interventions

DRUG

Basal insulin

daily basal insulin dose

DEVICE

Dexcom Continuous Glucose Monitoring (CGM)

Dexcom Continuous Glucose Monitoring (CGM) Sensor

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-11
Primary Completion
2026-01-16
Completion
2027-01-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07681375 on ClinicalTrials.gov